Literature DB >> 24880852

Conservative treatment for a growing patient with a severe, developing skeletal Class III malocclusion and open bite.

Yue Xu1, Ping Zhu2, Linda Le3, Bin Cai4.   

Abstract

An 8-year-old Chinese girl sought treatment for a severe skeletal Class III malocclusion and open-bite skeletal pattern. Traditionally, patients with a skeletal Class III malocclusion are treated after they have stopped growing, and then they are treated with a combined orthodontic and orthognathic surgery approach. But the risks and expenses of this treatment plan are not acceptable to all patients. This young patient was treated with facemask therapy, a maxillary expansion device, and a molar occlusal splint for maxillary developmental stimulation with control of vertical jaw growth. After the completion of orthopedic therapy, 2 × 4 technology was used to adjust molar positions. A bonded tongue crib was used in the early permanent dentition to help the patient break her bad tongue habits. Straight-wire appliances were used for 16 months to adjust the occlusal relationship. This achieved significant improvement in anterior tooth relationships and facial profile esthetics. At the 2-year posttreatment follow-up, the results were satisfactory. The success of the sagittal relationship correction between the maxilla and the mandible for a skeletal Class III malocclusion depends on the coordination of transverse and vertical relationships combined with the growth potential of each patient.
Copyright © 2014 American Association of Orthodontists. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24880852     DOI: 10.1016/j.ajodo.2013.08.020

Source DB:  PubMed          Journal:  Am J Orthod Dentofacial Orthop        ISSN: 0889-5406            Impact factor:   2.650


  1 in total

1.  Severe Angle Class III skeletal malocclusion associated to mandibular prognathism: orthodontic-surgical treatment.

Authors:  Marcelo Quiroga Souki
Journal:  Dental Press J Orthod       Date:  2016 Nov-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.